Nebivolol Promising Option for Management of Pulmonary Hypertension | Journal Scan

Study Questions:

Does nebivolol, a β1 antagonist and β2,3-agonist improve pulmonary arterial hypertension (PAH) in an experimental model, and reverse the PAH-related phenotype of pulmonary endothelial cells (P-EC)?